DNA methylation profiles differ in responders versus non-responders to anti-PD-1 immune checkpoint inhibitors in patients with advanced and metastatic head and neck squamous cell carcinoma
============================================================================================================================================================================================

* Angelika Martina Starzer
* Gerwin Heller
* Erwin Tomasich
* Thomas Melchardt
* Katharina Feldmann
* Teresa Hatziioannou
* Stefan Traint
* Christoph Minichsdorfer
* Ursula Schwarz-Nemec
* Maja Nackenhorst
* Leonhard Müllauer
* Matthias Preusser
* Anna Sophie Berghoff
* Thorsten Fuereder